Patrick James Orme

Array ( [id] => 7263566 [patent_doc_number] => 20040241731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Methods of producing nucleic acid ligands' [patent_app_type] => new [patent_app_number] => 10/818954 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 19341 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241731.pdf [firstpage_image] =>[orig_patent_app_number] => 10818954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5141303 [patent_doc_number] => 20070003519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Targets for tumor growth inhibition' [patent_app_type] => utility [patent_app_number] => 10/551667 [patent_app_country] => US [patent_app_date] => 2004-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 66 [patent_no_of_words] => 35453 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003519.pdf [firstpage_image] =>[orig_patent_app_number] => 10551667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7249326 [patent_doc_number] => 20040258656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'High affinity TGFbeta nucleic acid ligands and inhibitors' [patent_app_type] => new [patent_app_number] => 10/812642 [patent_app_country] => US [patent_app_date] => 2004-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27833 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20040258656.pdf [firstpage_image] =>[orig_patent_app_number] => 10812642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9312034 [patent_doc_number] => 08653252 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'Short interfering RNA (siRNA) analogues' [patent_app_type] => utility [patent_app_number] => 10/550152 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 20 [patent_no_of_words] => 20246 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10550152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5153904 [patent_doc_number] => 20070036787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Insulin-induced gene as therapeutic target in diabetes' [patent_app_type] => utility [patent_app_number] => 10/553676 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7767 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20070036787.pdf [firstpage_image] =>[orig_patent_app_number] => 10553676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085863 [patent_doc_number] => 20070275914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Therapeutic Compositions' [patent_app_type] => utility [patent_app_number] => 10/548611 [patent_app_country] => US [patent_app_date] => 2004-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 147373 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275914.pdf [firstpage_image] =>[orig_patent_app_number] => 10548611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 619871 [patent_doc_number] => 07141375 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-28 [patent_title] => 'Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor' [patent_app_type] => utility [patent_app_number] => 10/791367 [patent_app_country] => US [patent_app_date] => 2004-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6593 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/141/07141375.pdf [firstpage_image] =>[orig_patent_app_number] => 10791367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325212 [patent_doc_number] => 20040138159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Oligonucletides for regulating the gene coding for tnf$g(a) and/or genes controlled thereby and use thereof' [patent_app_type] => new [patent_app_number] => 10/471716 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6150 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138159.pdf [firstpage_image] =>[orig_patent_app_number] => 10471716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7200003 [patent_doc_number] => 20050042209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom' [patent_app_type] => utility [patent_app_number] => 10/778859 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 29097 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042209.pdf [firstpage_image] =>[orig_patent_app_number] => 10778859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288083 [patent_doc_number] => 20040147475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA' [patent_app_type] => new [patent_app_number] => 10/772661 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12837 [patent_no_of_claims] => 131 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147475.pdf [firstpage_image] =>[orig_patent_app_number] => 10772661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7428598 [patent_doc_number] => 20040209358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Antisense modulation of sap-1 expression' [patent_app_type] => new [patent_app_number] => 10/484669 [patent_app_country] => US [patent_app_date] => 2004-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25171 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209358.pdf [firstpage_image] =>[orig_patent_app_number] => 10484669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7033650 [patent_doc_number] => 20050032160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Cell-based therapies for diabetes mellitus and other glucose intolerant states' [patent_app_type] => utility [patent_app_number] => 10/760732 [patent_app_country] => US [patent_app_date] => 2004-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 25469 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032160.pdf [firstpage_image] =>[orig_patent_app_number] => 10760732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7264985 [patent_doc_number] => 20040242521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Thio-siRNA aptamers' [patent_app_type] => new [patent_app_number] => 10/758488 [patent_app_country] => US [patent_app_date] => 2004-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15212 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242521.pdf [firstpage_image] =>[orig_patent_app_number] => 10758488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7440904 [patent_doc_number] => 20040185479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Modified oligonucleotides for use in gene modulation' [patent_app_type] => new [patent_app_number] => 10/757298 [patent_app_country] => US [patent_app_date] => 2004-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40121 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20040185479.pdf [firstpage_image] =>[orig_patent_app_number] => 10757298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7296359 [patent_doc_number] => 20040214330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Methods and means for obtaining modified phenotypes' [patent_app_type] => new [patent_app_number] => 10/755328 [patent_app_country] => US [patent_app_date] => 2004-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18992 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214330.pdf [firstpage_image] =>[orig_patent_app_number] => 10755328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955405 [patent_doc_number] => 20080188429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Synthetic siRNA compounds and methods for the downregulation of gene expression' [patent_app_type] => utility [patent_app_number] => 10/746951 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12734 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188429.pdf [firstpage_image] =>[orig_patent_app_number] => 10746951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7310468 [patent_doc_number] => 20040142897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Compositions and methods for inhibiting tumor growth and metastasis' [patent_app_type] => new [patent_app_number] => 10/735577 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 28578 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142897.pdf [firstpage_image] =>[orig_patent_app_number] => 10735577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 494695 [patent_doc_number] => 07211661 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-01 [patent_title] => 'Trans-excision-splicing ribozyme and methods of use' [patent_app_type] => utility [patent_app_number] => 10/730261 [patent_app_country] => US [patent_app_date] => 2003-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 17 [patent_no_of_words] => 10011 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211661.pdf [firstpage_image] =>[orig_patent_app_number] => 10730261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122337 [patent_doc_number] => 20050014166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Compositions and systems for the regulation of genes' [patent_app_type] => utility [patent_app_number] => 10/720987 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 32232 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014166.pdf [firstpage_image] =>[orig_patent_app_number] => 10720987 [rel_patent_id] =>[rel_patent_doc_number] =>)